The annual Phillip and Ruth Hettleman Prizes for Artistic and Scholarly Achievement have been awarded to four associate professors who exemplify groundbreaking and innovative research.
Tip Sheet: Cancer-busting broccoli sprout pills in space, trauma and healing among Indigenous people, how to boost HPV vaccinations fredhutch.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fredhutch.org Daily Mail and Mail on Sunday newspapers.
Fred Hutchinson Cancer Research Center, Seattle Childrenâs and UW Medicine Lay Groundwork for Historic Cancer Partnership
7.13.21
Fred Hutchinson Cancer Research Center, UW Medicine, Seattle Cancer Care Alliance and
Seattle Childrenâs are exploring a comprehensive collaboration aimed at bringing
groundbreaking research to patient care for children and adults
Fred Hutchinson Cancer Research Center, UW Medicine, Seattle Cancer Care Alliance and Seattle Children’s today announced plans to explore restructuring their longtime relationship to accelerate a shared mission of advancing diagnosis, treatment and pioneering of cures for cancer and other diseases.
If finalized and approved, the proposed restructure would establish an adult-focused oncology program and, separately, a pediatric oncology program. These programs would be collaborative and integrated with the innovative cancer research from Fred Hutch, UW Medicine and Seattle Children’s.
Chief Executive Officer
Karen E. Knudsen, MBA, Ph.D., is the chief executive officer of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network
SM (ACS CAN). As a well-respected cancer leader, researcher, and advocate, Dr. Knudsen guides the organization on our mission to save lives, celebrate lives, and lead the fight for a world without cancer. She has a strong commitment to ensuring that all people can benefit from the impact of our work.
Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health, one of only 71 National Cancer Institute-designated cancer centers recognized for their research and impact on cancer outcomes. While at Sidney Kimmel Cancer Center at Jefferson Health, Dr. Knudsen experienced firsthand how ACS improves the lives of cancer patients and their families through discovery, advocacy, and patient
City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer
City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline. Heightened levels of PSA in men may indicate the existence of prostate tumors.
Shiuan Chen, Ph.D., the Lester M. and Irene C. Finkelstein Chair in Biology, has been investigating the potential beneficial effects of white button mushroom (Agaricus bisporus) at City of Hope for about 20 years. His translational preclinical and clinical research has found that this bioactive food available in most supermarkets might prevent or slow the spread of prostate and breast cancers. The common fungus appears to block